Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lactoferrin - Metrodora Therapeutics

Next Previous
Drug Profile

Lactoferrin - Metrodora Therapeutics

Alternative Names: Bovine lactoferrin - Metrodora Therapeutics

Latest Information Update: 28 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Metrodora Therapeutics
  • Class Adjuvants; Anti-inflammatories; Antibacterials; Antifungals; Glycoproteins; Iron binding proteins; Proteins
  • Mechanism of Action Chelating agents; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Necrotising enterocolitis; Sepsis
  • New Molecular Entity No

Highest Development Phases

  • No development reported Bacterial vaginosis; Crohn's disease

Most Recent Events

  • 28 Dec 2024 No recent reports of development identified for phase-I development in Bacterial-vaginosis(In volunteers) in Australia (Vaginal, Tablet)
  • 07 Apr 2022 Metrodora Therapeutics plans a phase I trial for Bacterial vaginosis (Prevention) in Australia (Vaginal) in April 2022 (ACTRN12622000548730)
  • 08 Nov 2021 Phase-I clinical trials in Bacterial vaginosis (In volunteers) (Vaginal) in Australia (ACTRN12621000862842)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top